AbbVie Inc (ABBV)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$194.00
Buy
$194.18
$-1.06 (-0.54%)
AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
Prices updated at 01 May 2025, 17:59 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Drug Manufacturers - General
Chairman
Mr. Richard A. Gonzalez
CEO
Mr. Robert A. Michael
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
50,000
Head office
1 North Waukegan Road
North Chicago
United States
60064-6400
Key personnel
| Owner name | Salary | Bonus | All other compensation | Total compensation | Restricted stock award |
|---|---|---|---|---|---|
Mr. Glenn F. Tilton Independent Director | 0.16m | - | - | 0.42m | - |
Mr. Richard A. Gonzalez Chairman of the Board | 1.60m | - | - | 28.50m | - |
Ms. Roxanne S. Austin Lead Independent Director | 0.16m | - | - | 0.46m | - |
Mr. Robert A. Michael Director and Chief Executive Officer | 1.61m | - | - | 18.49m | - |
Mr. Frederick H. Waddell Independent Director | 0.14m | - | - | 0.41m | - |
Ms. Rebecca B. Roberts Independent Director | 0.12m | - | - | 0.38m | - |
Dr. Robert J. Alpern,M.D. Independent Director | 0.12m | - | - | 0.53m | - |
Mr. Thomas C. Freyman Independent Director | 0.15m | - | - | 0.38m | - |
Mr. Edward J. Rapp Independent Director | 0.14m | - | - | 0.41m | - |
Mr. Brett J. Hart Independent Director | 0.15m | - | - | 0.38m | - |
Mr. Timothy J. Richmond Executive Vice President and Chief Human Resources Officer | 1.02m | - | - | 10.30m | - |
Dr. Azita Saleki-Gerhardt, B.S.,M.S.,PhD Executive Vice President and Chief Operations Officer | 1.02m | - | - | 9.92m | - |
Mr. William H.L. Burnside Independent Director | 0.13m | - | - | 0.37m | - |
Ms. Melody B. Meyer Independent Director | 0.14m | - | - | 0.40m | - |
Mr. Jeffrey Ryan Stewart Executive Vice President and Chief Commercial Officer | 1.28m | - | - | 14.05m | - |
Dr. Nicholas J. Donoghoe, M.D. Executive Vice President, Chief Business and Strategy Officer | - | - | - | - | - |
Mr. Scott Reents Executive Vice President and Chief Financial Officer | 1.07m | - | - | 10.99m | - |
Ms. Jennifer L. Davis Independent Director | 0.12m | - | - | 0.36m | - |
Mr. Perry C. Siatis Executive Vice President, General Counsel and Secretary | - | - | - | - | - |
Mr. Kevin K. Buckbee Senior Vice President, Controller and Principal Accounting Officer | - | - | - | - | - |
Dr. Susan E. Quaggin, M.D. Independent Director | 0.12m | - | - | 0.35m | - |
Dr. Roopal Thakkar, M.D. Executive Vice President, Research and Development and Chief Scientific Officer | - | - | - | - | - |
Top 5 shareholders
| Owner name | No. of shares | Share as % of port. | Last change | Portfolio % change | Date of portfolio | % Total assets |
|---|---|---|---|---|---|---|
| Vanguard Group Inc | 173,072,078 | 0.53569 | 1424237 | 0.829744 | 31 Mar 2025 | 9.78 |
| BlackRock Inc | 142,035,565 | 0.51072 | 6062998 | 4.458986 | 31 Mar 2025 | 8.03 |
| State Street Corp | 79,621,487 | 0.55816 | 553552 | 0.700097 | 31 Mar 2025 | 4.50 |
| Capital Research and Management Company | 69,126,645 | 37.38274 | -8700884 | - | 31 Mar 2025 | 3.91 |
| Vanguard Investments Australia Ltd | 56,864,736 | 7.63084 | 53486 | - | 31 Mar 2025 | 3.21 |
Director dealings
| Date | Action | Name | Price | Value | No. of shares | Holding (%) | Additional info |
|---|---|---|---|---|---|---|---|
| 31 Dec 2024 | - | Dr. Robert J. Alpern,M.D. | 177.70 | 7,463 | 9,788 | - | - |
| 31 Dec 2024 | - | Mr. Edward J. Rapp | 177.70 | 32,341 | 26,976 | - | - |
| 31 Dec 2024 | - | Dr. Susan E. Quaggin, M.D. | 177.70 | 14,927 | 401 | - | - |
| 16 Dec 2024 | - | Mr. Kevin K. Buckbee | 93.50 | 168,300 | 8,783 | - | - |
| 16 Dec 2024 | - | Mr. Kevin K. Buckbee | 93.50 | 168,300 | 12,111 | - | - |
| 16 Dec 2024 | - | Mr. Kevin K. Buckbee | 172.24 | 310,032 | 6,983 | - | - |
| 30 Sep 2024 | - | Dr. Robert J. Alpern,M.D. | 197.48 | 7,307 | 9,655 | - | - |
| 30 Sep 2024 | - | Mr. Edward J. Rapp | 197.48 | 32,387 | 26,544 | - | - |
| 30 Sep 2024 | - | Mr. Richard A. Gonzalez | - | - | 425,627 | - | - |
| 30 Sep 2024 | - | Mr. Richard A. Gonzalez | - | - | 441,356 | - | - |
| 30 Sep 2024 | - | Mr. Richard A. Gonzalez | - | - | 388,929 | - | - |
| 30 Sep 2024 | - | Dr. Susan E. Quaggin, M.D. | 197.48 | 14,811 | 314 | - | - |
| 24 Sep 2024 | - | Dr. Azita Saleki-Gerhardt, B.S.,M.S.,PhD | - | - | 194,348 | - | - |
| 05 Aug 2024 | - | Mr. Richard A. Gonzalez | 186.52 | 12,403,580 | 446,599 | - | - |
| 17 Jul 2024 | - | Mr. Richard A. Gonzalez | 79.02 | 9,436,410 | 719,567 | - | - |
| 17 Jul 2024 | - | Mr. Richard A. Gonzalez | - | - | 152,755 | - | - |
| 17 Jul 2024 | - | Mr. Richard A. Gonzalez | - | - | 59,709 | - | - |
| 17 Jul 2024 | - | Mr. Richard A. Gonzalez | - | - | - | - | - |
| 17 Jul 2024 | - | Mr. Richard A. Gonzalez | 175.00 | 49,497,875 | 513,099 | - | - |
| 17 Jul 2024 | - | Mr. Richard A. Gonzalez | 93.50 | 7,141,250 | 795,944 | - | - |
Please note that past performance is not a reliable indicator of future returns.
